| |
Latest 10 SEC filings (by transaction date) for ITCI within the last 6 months | |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 6/24 | Dec 5/24 | Mates Sharon | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -51,697 | |
Dec 6/24 | Dec 5/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -1,534 | $84.69 |
Dec 6/24 | Dec 5/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -50,163 | $84.06 |
Dec 6/24 | Dec 5/24 | Mates Sharon | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 51,697 | $12.73 |
Dec 6/24 | Dec 4/24 | Mates Sharon | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -51,000 | |
Dec 6/24 | Dec 4/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -23,333 | $86.00 |
Dec 6/24 | Dec 4/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -27,667 | $85.62 |
Dec 6/24 | Dec 4/24 | Mates Sharon | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 51,000 | $12.73 |
Nov 14/24 | Nov 13/24 | Halstead Michael | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -18,714 | |
Nov 14/24 | Nov 13/24 | Halstead Michael | Direct Ownership | Common Stock | S - Open market or private sale | -5,343 | $88.92 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ITCI within the last 6 months | |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 6/24 | Dec 5/24 | Mates Sharon | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -51,697 | |
Dec 6/24 | Dec 4/24 | Mates Sharon | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -51,000 | |
Dec 6/24 | Dec 5/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -1,534 | $84.69 |
Dec 6/24 | Dec 5/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -50,163 | $84.06 |
Dec 6/24 | Dec 5/24 | Mates Sharon | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 51,697 | $12.73 |
Dec 6/24 | Dec 4/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -23,333 | $86.00 |
Dec 6/24 | Dec 4/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -27,667 | $85.62 |
Dec 6/24 | Dec 4/24 | Mates Sharon | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 51,000 | $12.73 |
Nov 14/24 | Nov 13/24 | Halstead Michael | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -18,714 | |
Nov 14/24 | Nov 12/24 | Halstead Michael | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -22,869 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Avidity Biosciences (OQ:RNA) |
Catalyst Pharmaceuticals (OQ:CPRX) |
ADMA Biologics (OQ:ADMA) |